Bank of Montreal
ANRO icon

Bank of Montreal’s Alto Neuroscience ANRO Stock Holding History

Bank of Montreal’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
11,415
+72
+0.6% +$1.67K ﹤0.01% 2771
2026
Q1 		$255K Sell
11,343
-12
-0.1% -$222 ﹤0.01% 2786
2025
Q4 		$202K Buy
11,355
+13
+0.1% +$164 ﹤0.01% 2841
2025
Q3 		$45.6K Hold
11,342
– – ﹤0.01% 3143
2025
Q2 		$25K Buy
+11,342
New +$27K ﹤0.01% 3254

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of Montreal's ANRO Position: Q2 2026 in Review

Bank of Montreal increased its Alto Neuroscience (ANRO) stake by 0.63% in Q2 2026, buying an estimated $1.67K and bringing the position to 11,415 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #2771.

Bank of Montreal first reported a position in ANRO in Q2 2025 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Bank of Montreal held 11,415 shares of Alto Neuroscience worth $301K as of Q2 2026.
  • Bank of Montreal bought 72 Alto Neuroscience shares in Q2 2026, an estimated $1.67K.
  • Alto Neuroscience made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2771 holding.
  • Bank of Montreal first reported a position in Alto Neuroscience in Q2 2025 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.